BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3883170)

  • 1. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia.
    Kaplan NM; Carnegie A; Raskin P; Heller JA; Simmons M
    N Engl J Med; 1985 Mar; 312(12):746-9. PubMed ID: 3883170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypokalemia in thiazide-treated systemic hypertension.
    Maronde RF; Chan LS; Vlachakis N
    Am J Cardiol; 1986 Jul; 58(2):18A-21A. PubMed ID: 3524185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium supplementation ameliorates hypertension in patients with diuretic-induced hypokalemia.
    Kaplan NM
    Klin Wochenschr; 1985; 63 Suppl 3():122-4. PubMed ID: 3889487
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesis.
    Griffing GT; Melby JC
    Metabolism; 1989 Apr; 38(4):353-6. PubMed ID: 2725277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
    Kohvakka A
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):273-7. PubMed ID: 3045028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium supplementation fails to lower blood pressure in hypertensive patients receiving a potassium losing diuretic.
    Bulpitt CJ; Ferrier G; Lewis PJ; Daymond M; Bulpitt PF; Dollery CT
    Ann Clin Res; 1985; 17(4):126-30. PubMed ID: 3907484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium supplementation during diuretic therapy.
    Cooper I
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):555-63. PubMed ID: 808378
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors influencing serum potassium in treated hypertension.
    Ramsay LE; Boyle P; Ramsay MH
    Q J Med; 1977 Oct; 46(184):401-10. PubMed ID: 594295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of potassium chloride or triamterene in thiazide hypokalemia.
    Papademetriou V; Burris J; Kukich S; Freis ED
    Arch Intern Med; 1985 Nov; 145(11):1986-90. PubMed ID: 3904654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretic-induced hypokalemia.
    Schwartz AB
    Am Fam Physician; 1975 Jan; 11(1):101-4. PubMed ID: 1109534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic-induced hypokalemia in uncomplicated systemic hypertension: effect of plasma potassium correction on cardiac arrhythmias.
    Papademetriou V; Fletcher R; Khatri IM; Freis ED
    Am J Cardiol; 1983 Nov; 52(8):1017-22. PubMed ID: 6195908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt substitute as potassium replacement in hypertensive patients.
    Perry RS
    Clin Pharm; 1986 Feb; 5(2):156-9. PubMed ID: 3956125
    [No Abstract]   [Full Text] [Related]  

  • 14. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet.
    Grimm RH; Neaton JD; Elmer PJ; Svendsen KH; Levin J; Segal M; Holland L; Witte LJ; Clearman DR; Kofron P
    N Engl J Med; 1990 Mar; 322(9):569-74. PubMed ID: 2406601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretics and hypokalaemia: aldosterone antagonists or potassium supplementation?
    Demanet JC
    Acta Clin Belg; 1974; 29(3):176-8. PubMed ID: 4842207
    [No Abstract]   [Full Text] [Related]  

  • 17. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiologic and therapeutic analysis in patients with hypokalemic nonperiodic paralysis.
    Sung CC; Cheng CJ; Chiang WF; Chau T; Hsu YJ; Yang SS; Lin SH
    Am J Med; 2015 Mar; 128(3):289-96.e1. PubMed ID: 25447623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypokalemia during the treatment of arterial hypertension with diuretics.
    Lemieux G; Beauchemin M; Vinay P; Gougoux A
    Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.